Lupin inches up on plans of setting up two new R&D centres in US

07 Jul 2014 Evaluate

Lupin is currently trading at Rs. 1088.50, up by 0.65 points or 0.06 % from its previous closing of Rs. 1087.85 on the BSE.

The scrip opened at Rs. 1090.00 and has touched a high and low of Rs. 1092.00 and Rs. 1080.00 respectively. So far 6567 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1102.45 on 04-Jul-2014 and a 52 week low of Rs. 742.30 on 28-Aug-2013.

Last one week high and low of the scrip stood at Rs. 1102.45 and Rs. 1038.75 respectively. The current market cap of the company is Rs. 48757.80 crore.

The promoters holding in the company stood at 46.75 % while Institutions and Non-Institutions held 43.17 % and 10.08 % respectively.

In a view to focus on research in inhalation and on complex formulations, Pharma major Lupin is in the process of setting up two dedicated Centres of Excellence (CoE) for research in inhalation and complex injectables in Florida and Maryland in the US.

The company had also increased research and development spending to Rs 958.28 crore in FY 14 as compared to Rs 770.85 crore in the FY 13.

The company continues to invest heavily in its Research and Development (R&D) programmes and in FY 2014, the company invested 8.6% of its net sales in R&D and related spends, amounting to Rs 958.30 crore. It had invested 8.1% of its net sales in R&D and related spends amounting to Rs 770.85 crore in FY 13.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Lupin Share Price

2166.10 -12.10 (-0.56%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×